Obagi Medical Products, a subsidiary of Valeant Pharmaceuticals International Inc, announces a collaboration with Nextcell Medical Co to distribute Suzan Obagi, MD’s new line of skincare products in the United States.

Cosmetic surgeon and dermatologist Suzan Obagi established Nextcell Medical in 2013. In their strategic relationship, Obagi and Nextcell have joined forces to introduce Obagi’s new line of clinical skincare products, set to launch in midyear 2017. Obagi intends to continue to invest in Nextcell’s research and development efforts, notes a media release from Valeant Pharmaceuticals International Inc.

“I am so excited to finally unveil my line alongside the Obagi line of products,” says Obagi, in the release. “We have been working long and hard on designing a new concept of skin care for the modern patient. With our visions aligned, I can’t think of a better company than Obagi to introduce our products.”

“The relationship between Obagi and Nextcell is a forward move for this important brand,” states Joseph C. Papa, chairman and CEO of Valeant, in the release. “Dr Suzan Obagi brings extensive academic and clinical experience to the rich history of Obagi.”

“We are thrilled to have the opportunity to work with Obagi and continue to build on the brand’s already strong reputation and unsurpassed brand recognition,” adds Mazen F. Youssef, president and CEO of Nextcell. “We are confident our collaboration will accelerate the growth of both companies and complete Obagi’s portfolio with Dr Obagi’s novel innovations.”

[Source(s): Valeant Pharmaceuticals International Inc, PR Newswire]